<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Immunology and Molecular Pathology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/74389446-0D26-451F-BC60-01028C798AAD"><gtr:id>74389446-0D26-451F-BC60-01028C798AAD</gtr:id><gtr:firstName>Mala</gtr:firstName><gtr:otherNames>Kunti</gtr:otherNames><gtr:surname>Maini</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G108%2F515"><gtr:id>92F69582-CAC2-43D7-9102-46A4A425013F</gtr:id><gtr:title>Genomic analysis of the CD8 functional deficits associated with failure to control hepatitis B and hepatit</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G108/515</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2002-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>827873</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Medical and Dental Sciences</gtr:department><gtr:description>Role of NK cells in HBV-related liver damage</gtr:description><gtr:id>B24B5E9D-DF02-49F8-953E-A4140497126F</gtr:id><gtr:impact>Dunn et al JEM 2007</gtr:impact><gtr:outcomeId>37C264548BD-1</gtr:outcomeId><gtr:partnerContribution>Provision of valuable clinical samples and expertise in immunohistochemistry</gtr:partnerContribution><gtr:piContribution>Led research into novel mechanism of immune-mediated liver damage in HBV infection</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Infection and Immunity</gtr:department><gtr:description>T cell exhaustion</gtr:description><gtr:id>E680F1FD-6763-4F94-AFC7-740A9694C068</gtr:id><gtr:impact>Das et al, JEM 2008</gtr:impact><gtr:outcomeId>091E46A0141-1</gtr:outcomeId><gtr:partnerContribution>Expertise in the assessment of T cell senescence</gtr:partnerContribution><gtr:piContribution>Led the research into mechanims of exhaustion of T cells in HBV</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Infection and Immunity</gtr:department><gtr:description>Genomic analysis of T cells in HBV</gtr:description><gtr:id>D5909102-479E-4240-8DAA-34DEA377BDF0</gtr:id><gtr:impact>Lopes et al, JCI 2008 (publication list) International conference presentations</gtr:impact><gtr:outcomeId>6C73BA144FE-1</gtr:outcomeId><gtr:partnerContribution>Expert advice on the gene expression analysis of virus-specific T cells, including bioinformatics assistance with data analysis</gtr:partnerContribution><gtr:piContribution>Identification and purification of virus-specific Cd8 T cells. Expertise in the analysis of immune responses in chronic viral infections.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Primary school visit to institute</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>B69432E9-02EC-4FF4-BDCB-43570D420AD0</gtr:id><gtr:impact>Introducing primary school children to viral immunology on their visits to our institute with the help of an MRC Educator/artist.

Sessions very positively received and plan is to extend to other schools</gtr:impact><gtr:outcomeId>20E3D19A7AD</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient feedback sheet</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>0E0E62B4-8DD6-401D-9117-DE29DF4DBF9C</gtr:id><gtr:impact>Information sheet on findings of research for patients who have participated by donating blood for the study

Patients were happy to continue to participate in the study.</gtr:impact><gtr:outcomeId>A4C628DB28B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>650000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>103C2A7D-E6C4-4075-BA79-7A63FA92153A</gtr:id><gtr:outcomeId>0755B9F09850</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>315000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC New Investigator Grant</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>C9175408-4317-4878-9501-0C6E28EDD894</gtr:id><gtr:outcomeId>3DCF856DE1E0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UCLH Clinical Research and Development Committee</gtr:description><gtr:end>2008-10-02</gtr:end><gtr:fundingOrg>University College London Hospitals NHS Foundation Trust</gtr:fundingOrg><gtr:id>D783718B-F934-4BFE-AD72-2578BE87A2E8</gtr:id><gtr:outcomeId>7F06EBF4CE80</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>TRAIL and IL-8 can contribute to death of hepatocytes in HBV infection and bocking these may limit the toxicity of IFN-a therapy.</gtr:description><gtr:grantRef>G108/515</gtr:grantRef><gtr:id>B7E577BA-23A0-4D0B-B537-737BF7FFFA6F</gtr:id><gtr:impact>Other groups in the field of viral hepatitis have started examining the role of NK cells and the TRAIL pathway.</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>CFF42B3A1E7</gtr:outcomeId><gtr:patentId>US2010040632</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Use of a TRAIL-blocking monoclonal antibody to reduce toxicity of interferon-alpha treatment of chronic hepatitis B virus infection</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>4DE330D6-B25E-4720-9FED-577C8C6CE2D2</gtr:id><gtr:title>Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d10e93066e667cdd76d1e66f25e5b519"><gtr:id>d10e93066e667cdd76d1e66f25e5b519</gtr:id><gtr:otherNames>Das A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>1858CD23F0F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF70EBA5-8E32-4E0F-9D7A-A1F1F667DD96</gtr:id><gtr:title>Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a10439eb35b6873208116977e652748"><gtr:id>5a10439eb35b6873208116977e652748</gtr:id><gtr:otherNames>Dunn C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>7C8A793DF67</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4CD8F26-3EEF-4B60-8CDD-CFFBD171F2F8</gtr:id><gtr:title>IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d10e93066e667cdd76d1e66f25e5b519"><gtr:id>d10e93066e667cdd76d1e66f25e5b519</gtr:id><gtr:otherNames>Das A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_16010_20_22972930</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB12075D-4541-45BA-A5A6-2D4A1B0FA84D</gtr:id><gtr:title>Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1698428c495cfe11a822d0de219b7964"><gtr:id>1698428c495cfe11a822d0de219b7964</gtr:id><gtr:otherNames>Lopes AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>E33BF2DD6B9</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G108/515</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>